Our publications - Institut Roche

Rodallec, A., Franco, C., Robert, S. et al.

Prototyping Trastuzumab Docetaxel Immunoliposomes with a New FCM-Based Method to Quantify Optimal Antibody Density on Nanoparticles. Sci Rep 10, 4147 (2020).

https://doi.org/10.1038/s41598-020-60856-z

Rodallec, A., Sicard, G., Giacometti, S., Carre, M., Maia, T., Valette, M., Bouquet, F., Savina, A., Lacarelle, B., Ciccolini, J., & Fanciullino, R. (2020).

Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status: study of a docetaxel-trastuzumab immunoliposome on Her2+ breast cancer model (SKBR3). Anti-cancer drugs, 31(5), 463–472.

https://doi.org/10.1097/CAD.0000000000000878

Ighilahriz, M., Benfodda, M., Sharpe, H., Soufir, N., Mourah, S., Dumaz, N., Battistella, M., Savina, A., Bouquet, F., Nikolaev, S., & Basset-Seguin, N. (2019).

Vismodegib resistant mutations are not selected in multifocal relapses of locally advanced basal cell carcinoma after vismodegib discontinuation. Journal of the European Academy of Dermatology and Venereology, 33(11).

https://doi.org/10.1111/jdv.15741

Reger de Moura, C., Vercellino, L., Jouenne, F., Baroudjian, B., Sadoux, A., Louveau, B., Delyon, J., Serror, K., Goldwirt, L., Merlet, P., Bouquet, F., Battistella, M., Lebbé, C., & Mourah, S. (2020).

Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma. Translational oncology, 13(2), 275–286.

https://doi.org/10.1016/j.tranon.2019.10.003

Decaup, E., Rossi, C., Gravelle, P., Laurent, C., Bordenave, J., Tosolini, M., Tourette, A., Perrial, E., Dumontet, C., Poupot, M., Klein, C., Savina, A., Fournié, J. J., & Bezombes, C. (2019).

A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma. Frontiers in Immunology, 10.

https://doi.org/10.3389/fimmu.2019.01943

Briot, K., Jean, F., Jouni, A., Geoffray, M. M., Ly-Le Moal, M., Umbricht, D., Chatham, C., Murtagh, L., Delorme, R., Bouvard, M., Leboyer, M., & Amestoy, A. (2020).

Social Anxiety in Children and Adolescents With Autism Spectrum Disorders Contribute to Impairments in Social Communication and Social Motivation. Frontiers in Psychiatry, 11.

https://doi.org/10.3389/fpsyt.2020.00710

Bennabi, M., Tarantino, N., Gaman, A., Scheid, I., Krishnamoorthy, R., Debré, P., Bouleau, A., Caralp, M., Gueguen, S., Le-Moal, M. L., Bouvard, M., Amestoy, A., Delorme, R., Leboyer, M., Tamouza, R., & Vieillard, V. (2019).

Persistence of dysfunctional natural killer cells in adults with high-functioning autism spectrum disorders : stigma/consequence of unresolved early infectious events ? Molecular Autism, 10(1).

https://doi.org/10.1186/s13229-019-0269-1

Degos, C., Heinemann, M., Barrou, J., Boucherit, N., Lambaudie, E., Savina, A., Gorvel, L., & Olive, D. (2019).

Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function. Frontiers in Immunology, 10.

https://doi.org/10.3389/fimmu.2019.00877

Latour, S., Zanese, M., le Morvan, V., Vacher, A. M., Menard, N., Bijou, F., Durrieu, F., Soubeyran, P., Savina, A., Vacher, P., & Bresson-Bepoldin, L. (2019).

Role of Calcium Signaling in GA101-Induced Cell Death in Malignant Human B Cells. Cancers, 11(3), 291.

https://doi.org/10.3390/cancers11030291